Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Janus kinase pseudokinase domain (JH2) is a regulatory domain found in all members of the Janus kinase (JAK) family. The JH2 domain is located adjacent to the canonical tyrosine kinase domain (JH1) at the C-terminus of these proteins. It primarily functions as a negative regulator of the associated tyrosine kinase activity by direct interaction with the JH1 domain. Mutations in JH2 are implicated in hematological malignancies and other cancers, making it a potential therapeutic target.
Inhibition of JH2/JH1 interface, Modulation of ATP binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Janus Kinase Pseudokinase Domain (JH2).